Literature DB >> 27042834

Development, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.

H Schoemans1, K Goris1, R V Durm2, J Vanhoof3, D Wolff4, H Greinix5, S Pavletic6, S J Lee7, J Maertens1, S D Geest3,8, F Dobbels3,8, R F Duarte9.   

Abstract

The EBMT Complications and Quality of Life Working Party has developed a computer-based algorithm, the 'eGVHD App', using a user-centered design process. Accuracy was tested using a quasi-experimental crossover design with four expert-reviewed case vignettes in a convenience sample of 28 clinical professionals. Perceived usefulness was evaluated by the technology acceptance model (TAM) and User satisfaction by the Post-Study System Usability Questionnaire (PSSUQ). User experience was positive, with a median of 6 TAM points (interquartile range: 1) and beneficial median total, and subscale PSSUQ scores. The initial standard practice assessment of the vignettes yielded 65% correct results for diagnosis and 45% for scoring. The 'eGVHD App' significantly increased diagnostic and scoring accuracy to 93% (+28%) and 88% (+43%), respectively (both P<0.05). The same trend was observed in the repeated analysis of case 2: accuracy improved by using the App (+31% for diagnosis and +39% for scoring), whereas performance tended to decrease once the App was taken away. The 'eGVHD App' could dramatically improve the quality of care and research as it increased the performance of the whole user group by about 30% at the first assessment and showed a trend for improvement of individual performance on repeated case evaluation.

Entities:  

Mesh:

Year:  2016        PMID: 27042834     DOI: 10.1038/bmt.2016.26

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

2.  IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.

Authors:  P A Rowlings; D Przepiorka; J P Klein; R P Gale; J R Passweg; P J Henslee-Downey; J Y Cahn; S Calderwood; A Gratwohl; G Socié; M M Abecasis; K A Sobocinski; M J Zhang; M M Horowitz
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

3.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

4.  User-centered design and interactive health technologies for patients.

Authors:  Annette De Vito Dabbs; Brad A Myers; Kenneth R Mc Curry; Jacqueline Dunbar-Jacob; Robert P Hawkins; Alex Begey; Mary Amanda Dew
Journal:  Comput Inform Nurs       Date:  2009 May-Jun       Impact factor: 1.985

5.  Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.

Authors:  R F Duarte; H Greinix; B Rabin; S A Mitchell; G Basak; D Wolff; J A Madrigal; S Z Pavletic; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-08-19       Impact factor: 5.483

  5 in total
  7 in total

1.  eGVHD App: a new tool to improve graft-versus-host disease assessment.

Authors:  Marie Therese Rubio
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

Review 2.  Expanding Personalized, Data-Driven Dermatology: Leveraging Digital Health Technology and Machine Learning to Improve Patient Outcomes.

Authors:  Shannon Wongvibulsin; Tracy M Frech; Mary-Margaret Chren; Eric R Tkaczyk
Journal:  JID Innov       Date:  2022-02-01

Review 3.  Design Thinking in Health Care.

Authors:  Myra Altman; Terry T K Huang; Jessica Y Breland
Journal:  Prev Chronic Dis       Date:  2018-09-27       Impact factor: 2.830

4.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

Review 5.  Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.

Authors:  Hadir Shakshouk; Eric R Tkaczyk; Edward W Cowen; Rokea A El-Azhary; Shahrukh K Hashmi; Saad J Kenderian; Julia S Lehman
Journal:  Transplant Cell Ther       Date:  2021-06-06

6.  The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial.

Authors:  Helene M Schoemans; Kathy Goris; Raf Van Durm; Steffen Fieuws; Sabina De Geest; Steven Z Pavletic; Annie Im; Daniel Wolff; Stephanie J Lee; Hildegard Greinix; Rafael F Duarte; Xavier Poiré; Dominik Selleslag; Philippe Lewalle; Tessa Kerre; Carlos Graux; Frédéric Baron; Johan A Maertens; Fabienne Dobbels
Journal:  Haematologica       Date:  2018-06-14       Impact factor: 9.941

7.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.

Authors:  Carrie L Kitko; Joseph Pidala; Hélène M Schoemans; Anita Lawitschka; Mary E Flowers; Edward W Cowen; Eric Tkaczyk; Nosha Farhadfar; Sandeep Jain; Philipp Steven; Zhonghui K Luo; Yoko Ogawa; Michael Stern; Greg A Yanik; Geoffrey D E Cuvelier; Guang-Shing Cheng; Shernan G Holtan; Kirk R Schultz; Paul J Martin; Stephanie J Lee; Steven Z Pavletic; Daniel Wolff; Sophie Paczesny; Bruce R Blazar; Stephanie Sarantopoulos; Gerard Socie; Hildegard Greinix; Corey Cutler
Journal:  Transplant Cell Ther       Date:  2021-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.